生命科学资讯

Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris - BioSpace

Roche gets third pivotal win with MS drug, but liver signal could be a problem

FDA lifts hold on second Intellia Phase 3 gene editing trial

Stifel raises 10X Genomics stock price target on product adoption - Investing.com

Uniqure falls as FDA demands new trial for Huntington’s gene therapy

Med-tech outlook 2026: exits, financings, headwinds

Biggest gainers and losers for Feb. 23-27, 2026

Stifel raises 10X Genomics stock price target on product adoption - Investing.com

Candid to go public via reverse merger with Rallybio

10x Genomics (NASDAQ:TXG) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat

Bavarian Nordic CEO Paul Chaplin exits, months after failed $3B takeover

Ischemic stroke triggers brain-wide synaptic remodeling within four hours

Dynamic expectation strength and precision shape human pain perception through shared and dissociable α-oscillatory mechanisms

Behavioral convergence under urbanization: An overlooked dimension of biotic homogenization

Atrium Tx launches with Avidity's RNA ticker and cardio assets

Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris - Fox21Online

Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris - galvnews.com

Safety concerns spur Aardvark to halt key Prader-Willi drug trial

Big Pharma’s next entrant could come from China

Shionogi synthesizes new compounds for malaria